Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
17.91
-0.01 (-0.06%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CCRN stock have an average target of 18.31, with a low estimate of 18 and a high estimate of 18.61. The average target predicts an increase of 2.23% from the current stock price of 17.91.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CCRN stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Hold | 5 | 4 | 4 | 4 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 6 | 6 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 10, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $15 → $19 | Hold | Maintains | $15 → $19 | +3.91% | Dec 5, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +0.50% | Nov 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $15 | Hold | Maintains | $17 → $15 | -16.25% | Oct 21, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +6.09% | Aug 8, 2024 |
Financial Forecast
Revenue This Year
1.37B
from 2.02B
Decreased by -32.32%
Revenue Next Year
1.28B
from 1.37B
Decreased by -6.51%
EPS This Year
0.54
from 2.05
Decreased by -73.55%
EPS Next Year
0.59
from 0.54
Increased by 8.15%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.4B | 1.4B | 1.4B |
| Avg | 1.4B | 1.3B | 1.3B |
| Low | 1.3B | 1.2B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -30.2% | 0.4% | 7.4% |
| Avg | -32.3% | -6.5% | 3.2% |
| Low | -35.0% | -13.8% | -2.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.57 | 0.80 | 0.80 |
| Avg | 0.54 | 0.59 | 0.69 |
| Low | 0.50 | 0.37 | 0.58 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -72.3% | 47.2% | 36.1% |
| Avg | -73.5% | 8.1% | 17.8% |
| Low | -75.6% | -31.3% | -1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.